MARTÍN EDUARDO BRIZUELA; SANDRA ELIZABETH GOÑI; GEORGINA ALEXANDRA CARDAMA; MARÍA ALLEJANDRA ZINNI; ALEJANDRO ANDRÉS CASTELLO; LEANDRO MATÍAS SOMMESE; HERNÁN GABRIEL FARINA

Correlation of SARS-CoV-2 Viral Load and Clinical Evolution of Pediatric Patients in a General Hospital From Buenos Aires, Argentina.

Frontiers in pediatrics; Año: 2022 vol. 10 p. 1 - 7

GÓMEZ BERGNA SM; MARCHESINI A; AMORÓS MORALES LC; ARRÍAS PN; FARINA HG; ROMANOWSKI V; GOTTARDO MF; PIDRE ML

Exploring the Role of the Inhibitor of Apoptosis BIRC6 in Breast Cancer: A Database Analysis

JCO clinical cancer informatics; Lugar: New York; Año: 2022 p. 1 - 7

ROCIO SOLEDAD GARCIA-LAZARO; LORENA GISEL CALIGIURI; NORAILYS LORENZO; HUMBERTO LAMDAN; DANIEL FERNANDO ALONSO; HERNAN GABRIEL FARINA

Yerba Mate Modulates Tumor Cells Functions Involved in Metastasis in Breast Cancer Models

Frontiers in Pharmacology; Lugar: Switzerland; Año: 2021 vol. 12 p. 1 - 14

HUMBERTO LAMDAN; ROCÍO GARCÍA LAZARO; NORAILYS LORENZO; LORENA CALIGIURI; ALONSO DANIEL F.; FARINA HERNÁN G

Anti-proliferative Effects of a Blueberry Extract on a Panel of Tumor Cell Lines of Different Origin

EXPERIMENTAL ONCOLOGY; Lugar: kiev; Año: 2020 vol. 42 p. 101 - 108

PERERA, YASSER; YASSEL RAMOS; GABRIEL PADRÓN; EVELIN CABALLERO; OSMANY GUIROLA; LORENA CALIGIURI; NORAILYS LORENZO; MARÍA FLORENCIA GOTTARDO; FARINA HERNÁN G; ODILE FIHOL; CLAUDE COCHET; SILVIO E PEREA

CIGB-300 Anticancer Peptide Regulates the Protein Kinase CK2-dependent Phosphoproteome

MOLECULAR AND CELLULAR BIOCHEMISTRY; Lugar: Berlin; Año: 2020 vol. 470 p. 63 - 75

ROCÍO GARCÍA LAZARO; HUMBERTO LAMDAN; LORENA CALIGIURI; NORAILYS LORENZO; BEREGENO ANDREA; HUGO ORTEGA; ALONSO DANIEL F.; FARINA HERNÁN G

In vitro and in vivo antitumor activity of Yerba Mate extract in colon cancer models

JOURNAL OF FOOD SCIENCE; Lugar: Illinois; Año: 2020

GOTTARDO, MARIA F.; CAPOBIANCO, CARLA S.; SIDABRA, JOHANNA E.; GARONA, JUAN; PERERA, YASSER; PEREA, SILVIO E.; ALONSO, DANIEL F.; FARINA, HERNAN G.

Preclinical efficacy of CIGB-300, an anti-CK2 peptide, on breast cancer metastasic colonization

Scientific Reports; Lugar: London; Año: 2020 vol. 10

ALONSO, DANIEL F.; FARINA, HERNÁN G.

Repurposing of host-based therapeutic agents for the treatment of coronavirus disease 2019 (COVID-19): a link between antiviral and anticancer mechanisms?

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS; Año: 2020 vol. 56

CHEVALIER MT; GARONA J; SOBOL NT; FARINA HG; ALONSO DF; ÁLVAREZ VA

In vitro and in vivo evaluation of desmopressin-loaded poly(D,L-lactic-co-glycolic acid) nanoparticles for its potential use in cancer treatment

NANOMEDICINE; Lugar: Londres; Año: 2018 vol. 22 p. 2835 - 2849

MERARI T. CHEVALIER; MÓNICA C. GARCÍA; DANIELA GONZALEZ; SANDRO M. GOMESFILHO; DANIELA S. BASSÈRES; HERNÁN FARINA; VERA A. ALVAREZ

Preparation, characterization and in vitro evaluation of ε-polylysine-loaded polymer blend microparticles for potential pancreatic cancer therapy

JOURNAL OF MICROENCAPSULATION; Lugar: Londres; Año: 2017 vol. 34 p. 582 - 591

CIRIGLIANO SM; DÍAZ BESSONE MI; BERARDI DE; FLUMIAN C; BAL DE KIER JOFFÉ ED; PEREA SE; FARINA HG; TODARO LB; URTREGER AJ

The synthetic peptide CIGB-300 modulates CK2-dependent signaling pathways affecting the survival and chemoresistance of non-small cell lung cancer cell lines

CANCER CELL INTERNATIONAL; Lugar: Londres; Año: 2017 vol. 31 p. 1 - 16

CIRIGLIANO S; DÍAZ BESSONE MI; FLUMIAN C; BERARDI D; PEREA S; DE KIER JOFFÉ EB; FARINA H; TODARO L; URTREGER A

The Synthetic Peptide CIGB-300 Inhibits NF-κB Translocation Affecting the Survival and Chemoresistance of NSCLC Cell Lines

JOURNAL OF THORACIC ONCOLOGY; Lugar: Philadelphia; Año: 2016 p. 218 - 219

BENAVENT F; CAPOBIANCO CS; GARONA J; CIRIGLIANO SM; PERERA Y; URTREGER AJ; PEREA SE; ALONSO DF; FARINA HG

CIGB-300, an anti-CK2 peptide, inhibits angiogenesis, tumor cell invasion and metastasis in lung cancer models.

LUNG CANCER; Lugar: Amsterdam; Año: 2016 p. 14 - 21

PERERA Y; PEDROSO S; BORRAS-HIDALGO O; VÁZQUEZ DM; MIRANDA J; VILLAREAL A; FALCÓN V; CRUZ L; RODRIÌGUEZ-ULLOA A, RAMOS Y, GIL J, PERERA Y, CASTELLANOS-SERRA L, GARCIÌA Y, BETANCOURT L, BESADA V, GONZAÌLEZ LJ, FERNAÌNDEZ-DE-COSSIO J, SANCHEZ A, SERRANO JM, FARINA H, ALONSO DF, ACEVEDO BE, PADROÌN G, MUSACCHIO A, PEREA SE.J; PEREA SE

Pharmacologic inhibition of the CK2-mediated phosphorylation of B23/NPM in cancer cells selectively modulates genes related to protein synthesis, energetic metabolism, and ribosomal biogenesis.

MOLECULAR AND CELLULAR BIOCHEMISTRY; Lugar: Berlin; Año: 2015 vol. 404 p. 103 - 112

YASSER PERERA; NEYLEN DEL TORO; LARISA GOROVAYA; JORGE FERNANDEZ DE COSSIO; HERNAN G. FARINA; SILVIO E. PEREA

Synergistic interactions of the anti casein-kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models.

Molecular and Clinical Oncology; Lugar: Atenas; Año: 2014 vol. 6 p. 935 - 944

BENAVENT ACERO FR; PERERA NEGRIN Y; ALONSO DF; PEREA SE; GOMEZ DE; FARINA HG

Mechanisms of Cellular Uptake, Intracellular Transportation, and Degradation of CIGB-300, a Tat-Conjugated Peptide, in Tumor Cell Lines.

MOLECULAR PHARMACEUTICS; Lugar: Washington; Año: 2014 vol. 6 p. 1798 - 1807

MENGUAL GOMEZ, DIEGO L.; ARMANDO, ROMINA G.; FARINA, HERNÁN G.; GOMEZ, DANIEL E.

Telomerase and telomere: their structure and dynamics in health and disease

MEDICINA (BUENOS AIRES); Lugar: BUENOS AIRES; Año: 2014 vol. 74 p. 69 - 76

GÓMEZ DIEGO; FARINA HERNÁN G.; GOMEZ DANIEL E.

Telomerase regulation: A key to inhibition? (Review)

INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Atenas; Año: 2013 vol. 43 p. 1351 - 1356

BRAGADO P; ESTRADA Y; PARIKH F; KRAUSE S; CAPOBIANCO C; FARINA HG; SCHEWE DM; AGUIRRE-GHISO JA

TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling.

NATURE CELL BIOLOGY.; Lugar: Londres; Año: 2013 vol. 11 p. 1351 - 1361

GÓMEZ DL; FARINA HG; GÓMEZ DE

21. Telomerase regulation: A key to inhibition? (Review).

INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Atenas; Año: 2013 vol. 5 p. 1351 - 1356

RIPOLL GV; GARONA J; PIFANO M; FARINA HG; GOMEZ DE; ALONSO DF

Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model.

BREAST CANCER RESEARCH AND TREATMENT; Lugar: Berlin; Año: 2013 vol. 1 p. 9 - 18

GOMEZ DANIEL E.; ROMINA ARMANDO; FARINA HG; PABLO LORENZANO MENNA; CAROLINA CERRUDO; GHRINGHELLI PABLO DANIEL; ALONSO DF

Telomere structure and telomerase in health and disease (Review)

INTERNATIONAL JOURNAL OF ONCOLOGY; Lugar: Atenas; Año: 2012 vol. 41 p. 1561 - 1569

YASSER PERERA; COSTALES HC; DIAZ Y; REYES O; FARINA HG; MENDEZ L; GOMEZ RE; ACEVEDO BE; GOMEZ DE; ALONSO DF; PEREA SE

Sensitivity of tumor cells towards CIGB-300 anticancer peptide relies on its nucleolar localization.

JOURNAL OF PEPTIDE SCIENCE : AN OFFICIAL PUBLICATION OF THE EUROPEAN PEPTIDE SOCIETY.; Lugar: LOndres; Año: 2012 vol. 18 p. 215 - 223

HERMO GA, FARINA HG, ALONSO DF, GOMEZ DE

Effect of atorvastatin in a case of feline multicentric lymphoma - Case report.

ACTA VETERINARIA HUNGARICA; Lugar: BUDAPEST; Año: 2011 vol. 59 p. 69 - 76

PEREA SE; BALADRON I, GARCIA Y, PERERA Y, LOPEZ A, SORIANO JL, BATISTA N, PALAU, A, HERNÁNDEZ I,; FARINA H; GARCIA I, GONZALEZ L, GIL J, RODRIGUEZ A, SOLARES M, SANTANA A, CRUZ M, LOPEZ M, VALENZUELA C, REYES O, LÓPEZ-SAURA PA, GONZÁLEZ CA, DIAZ A, CASTELLANOS L, SANCHEZ A, BETANCOURT L, BESADA V, GONZÁLEZ LJ, GARAY H; GÓMEZ R, GÓMEZ DE, ALONSO DF; PERRIN P, RENUALT JY, SIGMAN H, HERRERA L, ACEVEDO B.

CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research.

MOLECULAR AND CELLULAR BIOCHEMISTRY; Lugar: Winnipeg; Año: 2011 vol. 356 p. 45 - 50

FARINA HERNÁN G. ; BENAVENT ACEROFERNANDO; YASSER PERERA; ARIELIS RODRÍGUEZ; PEREA SILVIO E.; ACEVEDO CASTRO BORIS ; GOMEZ ROBERTO ; ALONSO DANIEL F. ; GOMEZ DANIEL E.

CIGB-300, a proapoptotic peptide, inhibits angiogenesis in vitro and in vivo.

EXPERIMENTAL CELL RESEARCH; Lugar: Stockholm; Año: 2011 vol. 317 p. 1677 - 1688

RODRIÌGUEZ-ULLOA A, RAMOS Y, GIL J, PERERA Y, CASTELLANOS-SERRA L, GARCIÌA Y, BETANCOURT L, BESADA V, GONZAÌLEZ LJ, FERNAÌNDEZ-DE-COSSIO J, SANCHEZ A, SERRANO JM, FARINA H, ALONSO DF, ACEVEDO BE, PADROÌN G, MUSACCHIO A, PEREA SE.J

Proteomic Profile Regulated by the Anticancer Peptide CIGB-300 in Non-Small Cell Lung Cancer (NSCLC) Cells.

JOURNAL OF PROTEOME RESEARCH; Lugar: Washington; Año: 2010 vol. 9 p. 5473 - 5483

PABLO LORENZANO MENNA; ROMINA L. PARERA; GEORGINA A. CARDAMA; DANIEL F. ALONSO; DANIEL E. GOMEZ; HERNÁN G. FARINA

Enhanced cytostatic activity of statins in mouse mammary carcinoma cells overexpressing ß2-chimaerin.

MOLECULAR MEDICINE REPORTS; Lugar: greece; Año: 2009 p. 97 - 102

YASSER PERERA; HERNÁN G. FARINA; JEOVANIS GIL; ARIELIS RODRIGUEZ; FERNANDO BENAVENT; LILA CASTELLANOS; ROBERTO E. GÓMEZ; BORIS E. ACEVEDO; DANIEL F. ALONSO; SILVIO E. PEREA

Anticancer peptide CIGB-300 binds to nucleophosmin/B23, impairs its CK2-mediated phosphorylation, and leads to apoptosis through its nucleolar disassembly activity.

MOLECULAR CANCER THERAPEUTICS; Lugar: Philadelphia; Año: 2009 vol. 8 p. 1189 - 1196

PERERA Y; FARINA HG; HERNÁNDEZ I; MENDOZA O; SERRANO JM; REYES O; GÓMEZ DE; GÓMEZ RE; ACEVEDO BE; ALONSO DF; PEREA SE

Systemic administration of a peptide that impairs the protein kinase (CK2) phosphorylation reduces solid tumor growth in mice

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Lugar: United States; Año: 2008 vol. 1 p. 57 - 62

S.E. PEREA; O. REYES; I. BALADRON; Y. PERERA; H. FARINA; J. GIL; A. RODRIGUEZ; D. GOMEZ; R. GOMEZ; D.F. ALONSO; H. SIGMAN; L. HERRERA; B. ACEVEDO

CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo

MOLECULAR AND CELLULAR BIOCHEMISTRY; Lugar: Netherlands; Año: 2008 vol. 316 p. 163 - 167

HERNAN G. FARINA, MONICA POMIES, DANIEL F. ALONSO AND DANIEL E. GOMEZ

Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer.

ONCOLOGY REPORTS; Lugar: Athens , Greece; Año: 2006 vol. 16 p. 885 - 891

HERMO, G. RIPOLL, G,.V. FARINA, H,G. TURIC, E. GOBELLO, C. GOMEZ, D,E. ALONSO, D, F.

Uso veterinario de la desmopresina como adyuvante perioperatorio durante la extirpación de tumores sólidos

Veterinaria Cuyana; Lugar: San Luis; Año: 2006

GISELLE V. RIPOLL, HERNÁN G. FARINA, DANIEL E. GOMEZ, DANIEL F. ALONSO.

Desmopressin reduces melanoma lung metastasis in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1

IN VIVO; Lugar: Attiki 19014, Greece; Año: 2006

DE LORENZO MS, FARINA HG, ALONSO DF, GOMEZ DE.

Role of protein kinase C-dependent signaling pathways in the antiangiogenic properties of nafoxidine.

ANTICANCER RESEARCH; Lugar: Athens, Greece; Año: 2004 vol. 24 p. 1737 - 1743

ALONSO, DANIEL F, FARINA, HERNÁN G, TEJERA, AGUEDA M, GABRI MARIANO R, Y GOMEZ, DANIEL E.

Hacia nuevas formas de tratamiento del cáncer.

Ciencia Hoy; Lugar: Buenos Aires; Año: 2003 vol. 13 p. 30 - 35

FARINA, HERNÁN G, BUBLIK, DÉBORA R, ALONSO, DANIEL F, AND GOMEZ, DANIEL E.

Lovastatin Alters Cytoskeleton Organization and Inhibits Experimental Metastasis of Mammary Carcinoma Cells.

CLINICAL & EXPERIMENTAL METASTASIS; Lugar: Netherlands; Año: 2002 vol. 19 p. 551 - 559

ALONSO, DANIEL F, FARINA, HERNÁN G, ARREGUI, CARLOS, AON, MIGUEL AND GOMEZ, DANIEL E.

Modulation of Urokinase-Type Plasminogen Activator and Metalloproteinase Activities in Cultured Mouse Mammary-Carcinoma Cells: Enhancement by Paclitaxel and Inhibition by Nocodazole.

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Lugar: Switzerland; Año: 1999 vol. 83 p. 242 - 246

ALONSO, DANIEL F, FARINA, HERNÁN G, SKILTON, G, GABRI, MARIANO R , DE LORENZO, MARIANA, GÓMEZ, DANIEL E.

Reduction of mammary tumor formation and metastasis by Lovastatin, an inhibitor of mevalonate pathway of cholesterol synthesis

BREAST CANCER RESEARCH AND TREATMENT; Lugar: NY, EEUU.; Año: 1998 vol. 50 p. 83 - 93

ALONSO DANIEL F, SKILTON GUILLERMO, FARINA HERNÁN G, DE LORENZO MARIANA S, GÓMEZ DANIEL E.

Modulation of growth and urokinase secretion by vasopressin and closely related nonapeptides in metastasic mouse mammary tumor cells.

INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER.; Lugar: Athens, Greece.; Año: 1997 vol. 10 p. 375 - 379